DOMINION DIAGNOSTICS, LLC
NORTH KINGSTON, RI

Founded in 1997, Dominion Diagnostics, LLC has been making waves in the healthcare sector with its focus on clinical drug monitoring solutions designed specifically for medical specialties such as addiction medicine. At the heart of their services lies cutting-edge urine drug testing aimed at improving patient treatment outcomes. Their headquarters are situated at 211 Circuit Drive, North Kingstown, Rhode Island, while they are legally incorporated in Florida (M09000001958) since May 21, 2009. Today, Dominion Diagnostics boasts nationwide recognition for its commitment to regulatory compliance, including its work with the FDA's Opioid REMS. Their network provider status covers over 80% of commercial enrollees across the United States. Robert M. Garvey Jr., the CEO, is an influential figure, also known for founding and chairing the Coalition for Excellence in Medication Monitoring (CEMM). His team includes Mark A. McSally, Esq., who plays a dual role as Chief Operating Officer and General Counsel since 2006. Round out this dynamic leadership group are Arthur Brookfield, Ken F. Indof, Mary P. Hauser, Dr. Charlene Johnson, David J. Molusis, and Sheri Machado-each boasting decades of expertise across healthcare diagnostics, addiction counseling, human resources, IT, financial management, and behavioral health. With a strong commitment to actionable clinical data, Dominion is dedicated to advancing patient care through responsible monitoring practices in collaboration with renowned bodies like the American Society of Addiction Medicine (ASAM). This ensures adherence to evidence-based guidelines for treating opioid use disorders. As a testament to their ongoing reliability, Dominion Diagnostics consistently adheres to strict compliance measures, as shown by their regular, detailed reporting.